nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxylamine—Cytolytic hepatitis—Ramipril—type 1 diabetes mellitus	0.166	0.18	CcSEcCtD
Doxylamine—Acute hepatic failure—Ramipril—type 1 diabetes mellitus	0.128	0.139	CcSEcCtD
Doxylamine—Polyuria—Ramipril—type 1 diabetes mellitus	0.0213	0.023	CcSEcCtD
Doxylamine—Haemolytic anaemia—Ramipril—type 1 diabetes mellitus	0.0207	0.0224	CcSEcCtD
Doxylamine—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.0171	0.0185	CcSEcCtD
Doxylamine—Breast disorder—Ramipril—type 1 diabetes mellitus	0.0169	0.0183	CcSEcCtD
Doxylamine—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.0168	0.0182	CcSEcCtD
Doxylamine—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.0168	0.0182	CcSEcCtD
Doxylamine—Bronchospasm—Ramipril—type 1 diabetes mellitus	0.0159	0.0172	CcSEcCtD
Doxylamine—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.0158	0.0171	CcSEcCtD
Doxylamine—Sweating increased—Ramipril—type 1 diabetes mellitus	0.0157	0.017	CcSEcCtD
Doxylamine—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.0155	0.0167	CcSEcCtD
Doxylamine—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.0153	0.0166	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.0143	0.0154	CcSEcCtD
Doxylamine—Sweating—Ramipril—type 1 diabetes mellitus	0.0138	0.0149	CcSEcCtD
Doxylamine—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.0134	0.0145	CcSEcCtD
Doxylamine—Hepatitis—Ramipril—type 1 diabetes mellitus	0.0129	0.014	CcSEcCtD
Doxylamine—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.0122	0.0132	CcSEcCtD
Doxylamine—Flushing—Ramipril—type 1 diabetes mellitus	0.012	0.013	CcSEcCtD
Doxylamine—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.0117	0.0126	CcSEcCtD
Doxylamine—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.0117	0.0126	CcSEcCtD
Doxylamine—Erythema—Ramipril—type 1 diabetes mellitus	0.0113	0.0122	CcSEcCtD
Doxylamine—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.0108	0.0117	CcSEcCtD
Doxylamine—Tremor—Ramipril—type 1 diabetes mellitus	0.0105	0.0114	CcSEcCtD
Doxylamine—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.0104	0.0113	CcSEcCtD
Doxylamine—Benzphetamine—SLC18A2—type 1 diabetes mellitus	0.0104	0.187	CrCbGaD
Doxylamine—Agitation—Ramipril—type 1 diabetes mellitus	0.0103	0.0112	CcSEcCtD
Doxylamine—Angioedema—Ramipril—type 1 diabetes mellitus	0.0103	0.0111	CcSEcCtD
Doxylamine—Malaise—Ramipril—type 1 diabetes mellitus	0.0102	0.011	CcSEcCtD
Doxylamine—Vertigo—Ramipril—type 1 diabetes mellitus	0.0101	0.0109	CcSEcCtD
Doxylamine—Leukopenia—Ramipril—type 1 diabetes mellitus	0.0101	0.0109	CcSEcCtD
Doxylamine—Palpitations—Ramipril—type 1 diabetes mellitus	0.00995	0.0108	CcSEcCtD
Doxylamine—Convulsion—Ramipril—type 1 diabetes mellitus	0.00975	0.0105	CcSEcCtD
Doxylamine—Anxiety—Ramipril—type 1 diabetes mellitus	0.00955	0.0103	CcSEcCtD
Doxylamine—Discomfort—Ramipril—type 1 diabetes mellitus	0.00947	0.0102	CcSEcCtD
Doxylamine—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00937	0.0101	CcSEcCtD
Doxylamine—Confusional state—Ramipril—type 1 diabetes mellitus	0.00926	0.01	CcSEcCtD
Doxylamine—Dimetindene—CHRM2—type 1 diabetes mellitus	0.00925	0.166	CrCbGaD
Doxylamine—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00919	0.00993	CcSEcCtD
Doxylamine—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00901	0.00974	CcSEcCtD
Doxylamine—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.009	0.00973	CcSEcCtD
Doxylamine—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00897	0.0097	CcSEcCtD
Doxylamine—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00888	0.0096	CcSEcCtD
Doxylamine—Anorexia—Ramipril—type 1 diabetes mellitus	0.00876	0.00947	CcSEcCtD
Doxylamine—Hypotension—Ramipril—type 1 diabetes mellitus	0.00859	0.00928	CcSEcCtD
Doxylamine—Insomnia—Ramipril—type 1 diabetes mellitus	0.00831	0.00899	CcSEcCtD
Doxylamine—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00819	0.00886	CcSEcCtD
Doxylamine—Somnolence—Ramipril—type 1 diabetes mellitus	0.00817	0.00883	CcSEcCtD
Doxylamine—Disopyramide—CHRM2—type 1 diabetes mellitus	0.00802	0.144	CrCbGaD
Doxylamine—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00799	0.00864	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00793	0.00858	CcSEcCtD
Doxylamine—Fatigue—Ramipril—type 1 diabetes mellitus	0.00792	0.00856	CcSEcCtD
Doxylamine—Constipation—Ramipril—type 1 diabetes mellitus	0.00786	0.0085	CcSEcCtD
Doxylamine—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00757	0.00819	CcSEcCtD
Doxylamine—Urticaria—Ramipril—type 1 diabetes mellitus	0.0073	0.00789	CcSEcCtD
Doxylamine—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00677	0.00732	CcSEcCtD
Doxylamine—Asthenia—Ramipril—type 1 diabetes mellitus	0.00659	0.00713	CcSEcCtD
Doxylamine—Pruritus—Ramipril—type 1 diabetes mellitus	0.0065	0.00703	CcSEcCtD
Doxylamine—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00629	0.0068	CcSEcCtD
Doxylamine—Dizziness—Ramipril—type 1 diabetes mellitus	0.00608	0.00657	CcSEcCtD
Doxylamine—Brompheniramine—CHRM2—type 1 diabetes mellitus	0.00596	0.107	CrCbGaD
Doxylamine—Vomiting—Ramipril—type 1 diabetes mellitus	0.00584	0.00632	CcSEcCtD
Doxylamine—Rash—Ramipril—type 1 diabetes mellitus	0.00579	0.00626	CcSEcCtD
Doxylamine—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00579	0.00626	CcSEcCtD
Doxylamine—Nausea—Ramipril—type 1 diabetes mellitus	0.00546	0.0059	CcSEcCtD
Doxylamine—Diphenhydramine—CHRM2—type 1 diabetes mellitus	0.00397	0.0714	CrCbGaD
Doxylamine—Doxepin—CHRM2—type 1 diabetes mellitus	0.00385	0.0693	CrCbGaD
Doxylamine—Orphenadrine—CHRM2—type 1 diabetes mellitus	0.00375	0.0675	CrCbGaD
Doxylamine—Promazine—CHRM2—type 1 diabetes mellitus	0.00342	0.0616	CrCbGaD
Doxylamine—CHRM1—Muscarinic acetylcholine receptors—CHRM2—type 1 diabetes mellitus	0.00334	0.171	CbGpPWpGaD
Doxylamine—Imipramine—CHRM2—type 1 diabetes mellitus	0.003	0.0539	CrCbGaD
Doxylamine—Amitriptyline—CHRM2—type 1 diabetes mellitus	0.00298	0.0536	CrCbGaD
Doxylamine—Amitriptyline—ALB—type 1 diabetes mellitus	0.00102	0.0183	CrCbGaD
Doxylamine—HRH1—Monoamine GPCRs—CHRM2—type 1 diabetes mellitus	0.00074	0.0379	CbGpPWpGaD
Doxylamine—CHRM1—Monoamine GPCRs—CHRM2—type 1 diabetes mellitus	0.000737	0.0378	CbGpPWpGaD
Doxylamine—HRH1—Amine ligand-binding receptors—CHRM2—type 1 diabetes mellitus	0.000622	0.0318	CbGpPWpGaD
Doxylamine—CHRM1—Amine ligand-binding receptors—CHRM2—type 1 diabetes mellitus	0.00062	0.0317	CbGpPWpGaD
Doxylamine—HRH1—Monoamine GPCRs—ADRB1—type 1 diabetes mellitus	0.000543	0.0278	CbGpPWpGaD
Doxylamine—CHRM1—Monoamine GPCRs—ADRB1—type 1 diabetes mellitus	0.000541	0.0277	CbGpPWpGaD
Doxylamine—HRH1—Amine ligand-binding receptors—ADRB1—type 1 diabetes mellitus	0.000456	0.0234	CbGpPWpGaD
Doxylamine—CHRM1—Amine ligand-binding receptors—ADRB1—type 1 diabetes mellitus	0.000455	0.0233	CbGpPWpGaD
Doxylamine—CHRM1—Regulation of Actin Cytoskeleton—FGF21—type 1 diabetes mellitus	0.000409	0.0209	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—PAX4—type 1 diabetes mellitus	0.000287	0.0147	CbGpPWpGaD
Doxylamine—HRH1—IL-4 Signaling Pathway—IL4—type 1 diabetes mellitus	0.000255	0.0131	CbGpPWpGaD
Doxylamine—CHRM1—Calcium Regulation in the Cardiac Cell—CHRM2—type 1 diabetes mellitus	0.000221	0.0113	CbGpPWpGaD
Doxylamine—CHRM1—Regulation of Actin Cytoskeleton—CHRM2—type 1 diabetes mellitus	0.000221	0.0113	CbGpPWpGaD
Doxylamine—CHRM1—Calcium Regulation in the Cardiac Cell—ITPR3—type 1 diabetes mellitus	0.000198	0.0101	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—PRF1—type 1 diabetes mellitus	0.000194	0.00992	CbGpPWpGaD
Doxylamine—HRH1—G alpha (q) signalling events—ITPR3—type 1 diabetes mellitus	0.000166	0.00849	CbGpPWpGaD
Doxylamine—CHRM1—G alpha (q) signalling events—ITPR3—type 1 diabetes mellitus	0.000165	0.00846	CbGpPWpGaD
Doxylamine—HRH1—IL-4 Signaling Pathway—TYK2—type 1 diabetes mellitus	0.000165	0.00843	CbGpPWpGaD
Doxylamine—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB1—type 1 diabetes mellitus	0.000162	0.0083	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR3—type 1 diabetes mellitus	0.000148	0.00759	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR3—type 1 diabetes mellitus	0.000148	0.00757	CbGpPWpGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—CHRM2—type 1 diabetes mellitus	0.000143	0.00731	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—CHRM2—type 1 diabetes mellitus	0.000142	0.00729	CbGpPWpGaD
Doxylamine—CHRM1—Calcium Regulation in the Cardiac Cell—PRKCQ—type 1 diabetes mellitus	0.00014	0.00715	CbGpPWpGaD
Doxylamine—CHRM1—Regulation of Actin Cytoskeleton—VAV1—type 1 diabetes mellitus	0.000136	0.00695	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—GAL—type 1 diabetes mellitus	0.000132	0.00674	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—GAL—type 1 diabetes mellitus	0.000131	0.00672	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	0.00013	0.00666	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	0.00013	0.00666	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	0.00013	0.00664	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	0.00013	0.00664	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.000122	0.00626	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.000122	0.00624	CbGpPWpGaD
Doxylamine—HRH1—G alpha (q) signalling events—GCG—type 1 diabetes mellitus	0.000121	0.00621	CbGpPWpGaD
Doxylamine—CHRM1—G alpha (q) signalling events—GCG—type 1 diabetes mellitus	0.000121	0.00619	CbGpPWpGaD
Doxylamine—HRH1—G alpha (q) signalling events—PRKCQ—type 1 diabetes mellitus	0.000117	0.00598	CbGpPWpGaD
Doxylamine—CHRM1—G alpha (q) signalling events—PRKCQ—type 1 diabetes mellitus	0.000116	0.00596	CbGpPWpGaD
Doxylamine—HRH1—IL-4 Signaling Pathway—STAT3—type 1 diabetes mellitus	0.000115	0.0059	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—type 1 diabetes mellitus	0.000109	0.00556	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—type 1 diabetes mellitus	0.000108	0.00554	CbGpPWpGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.000105	0.00537	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCQ—type 1 diabetes mellitus	0.000104	0.00535	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.000104	0.00535	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCQ—type 1 diabetes mellitus	0.000104	0.00533	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.0001	0.00513	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—GAL—type 1 diabetes mellitus	9.98e-05	0.00511	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—CCL11—type 1 diabetes mellitus	9.9e-05	0.00507	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—CCL20—type 1 diabetes mellitus	9.9e-05	0.00507	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—CCL20—type 1 diabetes mellitus	9.87e-05	0.00506	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—CCL11—type 1 diabetes mellitus	9.87e-05	0.00506	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	9.31e-05	0.00477	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	9.28e-05	0.00475	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	9.02e-05	0.00462	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	8.99e-05	0.0046	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	8.98e-05	0.0046	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	8.95e-05	0.00458	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—IAPP—type 1 diabetes mellitus	7.82e-05	0.00401	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—IAPP—type 1 diabetes mellitus	7.79e-05	0.00399	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	7.49e-05	0.00384	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	7.47e-05	0.00382	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—CDK4—type 1 diabetes mellitus	7.2e-05	0.00369	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—NOS2—type 1 diabetes mellitus	7e-05	0.00358	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—SST—type 1 diabetes mellitus	6.87e-05	0.00352	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—SST—type 1 diabetes mellitus	6.84e-05	0.00351	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	6.83e-05	0.0035	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	6.81e-05	0.00349	CbGpPWpGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	6.78e-05	0.00347	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	6.76e-05	0.00346	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—GCG—type 1 diabetes mellitus	6.12e-05	0.00313	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—GCG—type 1 diabetes mellitus	6.1e-05	0.00312	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	5.81e-05	0.00298	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	5.79e-05	0.00297	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	5.7e-05	0.00292	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	5.69e-05	0.00291	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—GAL—type 1 diabetes mellitus	5.66e-05	0.0029	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—GAL—type 1 diabetes mellitus	5.64e-05	0.00289	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	5.6e-05	0.00287	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	5.58e-05	0.00286	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—type 1 diabetes mellitus	5.45e-05	0.00279	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—type 1 diabetes mellitus	5.43e-05	0.00278	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	5.26e-05	0.0027	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	5.25e-05	0.00269	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—GAL—type 1 diabetes mellitus	5.14e-05	0.00263	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—GAL—type 1 diabetes mellitus	5.12e-05	0.00262	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—CCL20—type 1 diabetes mellitus	5.08e-05	0.0026	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—CCL11—type 1 diabetes mellitus	5.08e-05	0.0026	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—CCL11—type 1 diabetes mellitus	5.07e-05	0.0026	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—CCL20—type 1 diabetes mellitus	5.07e-05	0.0026	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	4.78e-05	0.00245	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	4.76e-05	0.00244	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	4.72e-05	0.00242	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	4.71e-05	0.00241	CbGpPWpGaD
Doxylamine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—type 1 diabetes mellitus	4.63e-05	0.00237	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—CCR5—type 1 diabetes mellitus	4.42e-05	0.00227	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	4.42e-05	0.00226	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—CCR5—type 1 diabetes mellitus	4.41e-05	0.00226	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	4.4e-05	0.00226	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	4.29e-05	0.0022	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	4.28e-05	0.00219	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—IAPP—type 1 diabetes mellitus	4.01e-05	0.00206	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—IAPP—type 1 diabetes mellitus	4e-05	0.00205	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—SST—type 1 diabetes mellitus	3.88e-05	0.00199	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—SST—type 1 diabetes mellitus	3.87e-05	0.00198	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	3.86e-05	0.00198	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	3.85e-05	0.00197	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—SST—type 1 diabetes mellitus	3.52e-05	0.0018	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—SST—type 1 diabetes mellitus	3.51e-05	0.0018	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	3.51e-05	0.0018	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	3.5e-05	0.00179	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	3.47e-05	0.00178	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	3.46e-05	0.00177	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	3.46e-05	0.00177	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	3.45e-05	0.00177	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	3.33e-05	0.0017	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	3.32e-05	0.0017	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	3.23e-05	0.00166	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	3.22e-05	0.00165	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	3.22e-05	0.00165	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	3.21e-05	0.00165	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—GCG—type 1 diabetes mellitus	3.14e-05	0.00161	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—GCG—type 1 diabetes mellitus	3.13e-05	0.0016	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GAL—type 1 diabetes mellitus	3.04e-05	0.00156	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GAL—type 1 diabetes mellitus	3.03e-05	0.00155	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	3.02e-05	0.00155	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	3.01e-05	0.00154	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CCL11—type 1 diabetes mellitus	3e-05	0.00154	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CCL20—type 1 diabetes mellitus	3e-05	0.00154	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CCL20—type 1 diabetes mellitus	2.99e-05	0.00153	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CCL11—type 1 diabetes mellitus	2.99e-05	0.00153	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	2.94e-05	0.0015	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	2.93e-05	0.0015	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	2.93e-05	0.0015	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	2.92e-05	0.00149	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	2.82e-05	0.00145	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	2.81e-05	0.00144	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—IL6—type 1 diabetes mellitus	2.8e-05	0.00144	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	2.66e-05	0.00136	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	2.66e-05	0.00136	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	2.53e-05	0.0013	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	2.53e-05	0.00129	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	2.5e-05	0.00128	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	2.49e-05	0.00128	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	2.46e-05	0.00126	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	2.46e-05	0.00126	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	2.39e-05	0.00122	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	2.38e-05	0.00122	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—APOC3—type 1 diabetes mellitus	2.37e-05	0.00121	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IAPP—type 1 diabetes mellitus	2.37e-05	0.00121	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IAPP—type 1 diabetes mellitus	2.36e-05	0.00121	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—APOC3—type 1 diabetes mellitus	2.36e-05	0.00121	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	2.27e-05	0.00116	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	2.26e-05	0.00116	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	2.24e-05	0.00115	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	2.23e-05	0.00114	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—SST—type 1 diabetes mellitus	2.08e-05	0.00107	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—SST—type 1 diabetes mellitus	2.07e-05	0.00106	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.07e-05	0.00106	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.07e-05	0.00106	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GCG—type 1 diabetes mellitus	1.85e-05	0.00095	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GCG—type 1 diabetes mellitus	1.85e-05	0.000947	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.79e-05	0.000915	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.78e-05	0.000912	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.73e-05	0.000888	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.73e-05	0.000886	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.73e-05	0.000885	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.72e-05	0.000883	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.58e-05	0.000807	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.57e-05	0.000805	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.57e-05	0.000804	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.57e-05	0.000802	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CD86—type 1 diabetes mellitus	1.51e-05	0.000775	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CD86—type 1 diabetes mellitus	1.51e-05	0.000772	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.44e-05	0.00074	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.44e-05	0.000737	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.43e-05	0.000735	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.43e-05	0.000733	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.36e-05	0.000698	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.36e-05	0.000696	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.34e-05	0.000687	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.34e-05	0.000685	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.32e-05	0.000677	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.32e-05	0.000675	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.31e-05	0.000672	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.31e-05	0.00067	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CD80—type 1 diabetes mellitus	1.1e-05	0.000565	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CD80—type 1 diabetes mellitus	1.1e-05	0.000563	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—INS—type 1 diabetes mellitus	1.04e-05	0.000534	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—INS—type 1 diabetes mellitus	1.04e-05	0.000532	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.01e-05	0.000516	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	1e-05	0.000515	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1e-05	0.000514	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1e-05	0.000512	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.31e-06	0.000477	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.28e-06	0.000475	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NOS3—type 1 diabetes mellitus	9.14e-06	0.000468	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	9.11e-06	0.000467	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.76e-06	0.000397	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IL2—type 1 diabetes mellitus	7.75e-06	0.000397	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.74e-06	0.000396	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IL2—type 1 diabetes mellitus	7.72e-06	0.000396	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.71e-06	0.000395	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.69e-06	0.000394	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.52e-06	0.000334	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.5e-06	0.000333	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.93e-06	0.000304	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.91e-06	0.000303	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IL6—type 1 diabetes mellitus	4.55e-06	0.000233	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IL6—type 1 diabetes mellitus	4.54e-06	0.000233	CbGpPWpGaD
